34.2 C
Thursday, May 30, 2024

Latest Posts

Maersk partners with Novo Nordisk on cold chain logistics

Pharma producer chooses Maersk’s services to reduce transportation carbon footprint 

AP Moller-Maersk recently announced the signing of a logistics agreement with Danish pharmaceutical company Novo Nordisk from 2021. The three-year agreement on cold chain logistics covers transportation including ocean services and inland logistics.

“Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions. This achievement showcases the rapid transformation of AP Moller-Maersk as a modern end-to-end logistics company with fully controlled assets,” commented Vincent Clerc, Executive Vice President and CEO, Ocean and Logistics, AP Moller-Maersk.

One of the largest pharmaceutical companies in the world, Novo Nordisk has chosen Maersk´s ECO Delivery to reduce the carbon footprint in transportation. The initiative uses sustainable bio-fuel to power selected Maersk-vessels and helps Novo Nordisk to make progress towards its ambitious sustainability goals.

“Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business. We consider AP Moller–Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration,” remarked Rune Sylow, Corporate Vice President, Strategic Sourcing, Novo Nordisk.


The global agreement will be effective from1 April 2021.

Digital Issues

Latest Posts


Don't Miss

Stay in touch

To be updated with all the latest news, offers and special announcements.